产前咨询对妊娠期糖尿病女性产后随访及避孕使用的影响:一项随机对照试验
该随机对照试验纳入280例妊娠期糖尿病孕妇,比较产前咨询(孕35-36周)联合常规产后早期咨询与仅常规产后早期咨询的效果。结果显示,干预组产后6周内葡萄糖筛查率(86.4% vs 50.7%;调整相对风险1.70,95%CI 1.27-2.28)及高效避孕方法使用率(59.3% vs 30.7%;调整相对风险1.90,95%CI 1.31-2.74)均显著高于对照组,任何避孕方法使用率亦显著升高(87.1% vs 55.0%;调整相对风险1.58,95%CI 1.19-2.10)。
要点
- 产前咨询联合常规产后咨询可提高妊娠期糖尿病女性产后6周葡萄糖筛查率。
- 产前咨询联合常规产后咨询可提高高效避孕方法使用率。
- 作者认为将产后葡萄糖检测和有效避孕咨询纳入标准产前护理似乎可行。
核心结论
- 在常规产后早期咨询基础上增加产前咨询,可显著提高妊娠期糖尿病女性产后6周内的葡萄糖筛查率和避孕使用率。
- 鉴于将产后葡萄糖检测和有效避孕使用咨询纳入标准产前护理所需费用和人力增加极少,作者认为在临床实践中实施该咨询策略似乎是可取的。
研究设计与样本
- 随机对照试验,纳入280例诊断为妊娠期糖尿病的孕妇,按1:1随机分配(采用置换区组法分层)至干预组或对照组。
- 干预组在孕35-36周接受产前咨询加常规产后早期咨询;对照组仅接受常规产后早期咨询。
- 两个主要结局为产后6周内的葡萄糖筛查和高效避孕方法使用;次要结局为产后6周内任何避孕方法的使用。
- 数据分析按意向性治疗原则进行。
主要发现
- 产后葡萄糖筛查率:干预组86.4%(121/140)vs 对照组50.7%(71/140),调整相对风险1.70,95%CI 1.27-2.28。
- 高效避孕方法使用率:干预组59.3% vs 对照组30.7%,调整相对风险1.90,95%CI 1.31-2.74。
- 产后6周内任何避孕方法使用率:干预组87.1%(122/140)vs 对照组55.0%(77/140),调整相对风险1.58,95%CI 1.19-2.10。
临床怎么用
- 原文结论认为,在临床实践中实施产前咨询联合常规产后早期咨询的策略似乎是可取的。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Postpartum visit attendance for glucose screening and uptake of effective contraception is crucial after a pregnancy with gestational diabetes mellitus. Although postpartum women with recent gestational diabetes mellitus are generally advised in the early postnatal period to attend postpartum visits, data have shown suboptimal rates of postpartum glucose testing and of highly effective contraceptive use among these women. Compared with the early postnatal period, the antenatal period is when women and healthcare providers have more contact. This may facilitate a better relationship between the pregnant woman and her healthcare providers, thereby improving the women's trust in the providers' counseling. OBJECTIVE: This study aimed to investigate if adding prenatal counseling to routine, early-postnatal counseling increases the rates of glucose screening and contraceptive use by 6 weeks postpartum among pregnant women with gestational diabetes mellitus. STUDY DESIGN: A randomized controlled trial of 280 women diagnosed with gestational diabetes mellitus was conducted. Participants were randomly allocated (1:1, stratified using a permuted block method) to the intervention group (receiving prenatal counseling at 35-36 weeks of gestation plus routine, early-postnatal counseling) or the control group (receiving only routine, early-postnatal counseling). The 2 primary outcomes were glucose screening and highly effective contraceptive uptake by 6 weeks postpartum. The secondary outcome was the use of any contraceptive by 6 weeks postpartum. Data were analyzed according to the intention-to-treat principle. RESULTS: The rate of postpartum glucose screening was 86.4% (121/140) in the intervention group, which was significantly higher than the rate of 50.7% (71/140) in the control group (adjusted relative risk, 1.70; 95% confidence interval, 1.27-2.28). The uptake of highly effective contraceptive methods was increased in the intervention group when compared with the control group (59.3% vs 30.7%; adjusted relative risk, 1.90; 95% confidence interval, 1.31-2.74). The uptake of any contraceptive method by 6 weeks postpartum was reported by 122 of 140 participants (87.1%) in the intervention group and by 77 of 140 participants (55.0%) in the control group (adjusted relative risk, 1.58; 95% confidence interval, 1.19-2.10). CONCLUSION: Adding prenatal counseling to routine, early-postnatal counseling significantly increased the rates of glucose screening and contraceptive use by 6 weeks postpartum among pregnant women with gestational diabetes mellitus. Given that the incorporation of counseling on postpartum glucose testing and effective contraceptive use into standard prenatal care requires minimal increases in expenditure and manpower, implementation of this counseling strategy in clinical practice seems advisable.
引用
- Phaloprakarn C, Suthasmalee S. Effect of prenatal counseling on postpartum follow-up and contraceptive use in women with gestational diabetes mellitus: a randomized controlled trial. Am J Obstet Gynecol MFM. 2023. PMID: 37527735. doi:10.1016/j.ajogmf.2023.101107
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。